| Literature DB >> 8117128 |
O I Miller1, D S Celermajer, J E Deanfield, D J Macrae.
Abstract
Inhaled nitric oxide (NO) is a selective pulmonary vasodilator, potentially useful in the treatment of pulmonary hypertension and ventilation-perfusion mismatch. High doses of inhaled NO and its oxidative product nitrogen dioxide (NO2) may cause acute lung injury. Using a standard infant ventilator, ventilator circuit and test lung, an administration and monitoring strategy has been defined for inhaled NO and these observations validated in eight ventilated infants. In 90% oxygen, doses of inhaled NO > or = 80 parts per million may result in toxic NO2 concentrations.Entities:
Mesh:
Substances:
Year: 1994 PMID: 8117128 PMCID: PMC1060988 DOI: 10.1136/fn.70.1.f47
Source DB: PubMed Journal: Arch Dis Child Fetal Neonatal Ed ISSN: 1359-2998 Impact factor: 5.747